Summary of article found on WREX.com:The Biden administration proposed expanding Medicare and Medicaid coverage for costly anti-obesity drugs, potentially benefiting millions of seniors and low-income individuals. This could significantly reduce out-of-pocket expenses, but the proposal lacks details and faces uncertainty under the incoming Trump administration, with differing opinions from key appointees. Currently, limited access due to high drug costs restricts widespread use, and the financial implications for Medicare are substantial, with estimates reaching billions of dollars annually. While some private insurers are covering t ...